Article
MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by…
OncoTargets and Therapy · 2019 · Li C, Yu S, Wu S, Ni Y, Pan Z
Key facts
| Title | MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway |
|---|---|
| First author | Li C, Yu S, Wu S, Ni Y, Pan Z |
| Journal | OncoTargets and Therapy |
| Published | Jul 8, 2019 |
| DOI | 10.2147/OTT.S213231 |
| Devices mentioned | K810863 |
| Product codes mentioned | DBM, LXH, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1